The Efficacy of Ginsenoside Rg3 Combined with First-line Chemotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer in China: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Background: For advanced non-small cell lung cancer (NSCLC) patients, first-line chemotherapy is the main treatment in the clinic despite its efficacy is limited and adverse effects are always inescapable. Ginsenoside Rg3, an anti-cancer active ingredient by suppressing angiogenesis, has been increa...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Ze, Wu, Wen Wen, Yi, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012535/
https://www.ncbi.nlm.nih.gov/pubmed/33815097
http://dx.doi.org/10.3389/fphar.2020.630825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012535/
https://www.ncbi.nlm.nih.gov/pubmed/33815097
http://dx.doi.org/10.3389/fphar.2020.630825

Ejemplares similares